$MEDP · Medpace Holdings, Inc.
Medpace Holdings CEO August Troendle reported two open-market sales totaling 43,916 shares for $27,403,895. The transactions executed at prices between $621.33 and $628.64 per share. No 10b5-1 trading plan was indicated.
- CEO August Troendle sold 43,916 shares for $27,403,895 total across two transactions.
- Sale prices ranged from $621.33 to $628.64 per share.
- No 10b5-1 trading plan was in place for these dispositions.
- Troendle remains the largest shareholder with 389,456 shares post-sale.
- Troendle is President, CEO, Director, and 10% owner — a quadruple insider role.
Stock is down 0.28% in the regular session at $618.88. A $27.4M CEO sale without a 10b5-1 plan on a $17.27B market-cap company is notable but not destabilizing; the modest intraday decline suggests the market absorbed the signal without panic.
N/A
_Not applicable._
CEO sold without a 10b5-1 plan, meaning the trades were discretionary — this can signal reduced confidence in near-term valuation rather than routine portfolio diversification.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.